Live Breaking News & Updates on அந்தோணி லெம்போ

Stay updated with breaking news from அந்தோணி லெம்போ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New Allakos Data Presented at DDW 2021 Suggest that


New Allakos Data Presented at DDW 2021 Suggest that Eosinophilic Gastritis and/or Eosinophilic Duodenitis (EG/EoD) is Highly Underdiagnosed and may be a Common Cause of Moderate-to-Severe Gastrointestinal Symptoms
45% (181/405) of patients with chronic functional gastrointestinal symptoms who underwent upper endoscopy with biopsy met the diagnostic criteria for eosinophilic gastritis and/or eosinophilic duodenitis (EG/EoD)
May 24, 2021 07:00 ET
| Source:
Allakos Inc.
Allakos Inc.
Redwood City, California, UNITED STATES
REDWOOD CITY, Calif., May 24, 2021 (GLOBE NEWSWIRE) Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, reported data at Digestive Disease Week (DDW) 2021. Results from a prospective study examined the rates of elevated tissue eosinophils in patients with chronic unex ....

United States , Anthony Lembo , Nicholas Talley , Global Research , Company Phase , Division Of Gastroenterology , Company Nasdaq , Professor Of Medicine At Harvard Medical School , University Of North Carolina At Chapel Hill , Hepatology Department Of Medicine , Allakos Inc , University Of Newcastle , Digestive Disease Week , Associate Professor , Harvard Medical , Pro Vice Chancellor , Adjunct Professor , Hepatology Department , North Carolina , Prevalence Study , Eosinophilic Gastritis , New England Journal , Nasdaq Allk , Allakos Inc , ஒன்றுபட்டது மாநிலங்களில் , அந்தோணி லெம்போ ,